AstraZeneca Says US FDA Approves Expanded Indication For Brilinta
The drug, which is meant to prevent blood clots that can cause heart attacks and strokes, had previously been approved at a higher dose for use during the first year after a heart attack. It could also increase the numbers of patients eligible for the drug to include those who...
Posted On Sep 06 2015